DOI:
10.1055/s-00000105
Zentralblatt für Gynäkologie
LinksClose Window
References
Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J.
Recombinant humanized anti-HER2 antibody (Herceptin) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts.
Cancer Res 1998; 58 (13): 2825-2831
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.